Virtu Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,659
Closed -$142K 2311
2022
Q1
$142K Sell
10,659
-7,488
-41% -$100K 0.01% 895
2021
Q4
$283K Buy
18,147
+1,979
+12% +$37.8K 0.03% 655
2021
Q3
$363K Sell
16,168
-3,237
-17% -$71.1K 0.03% 621
2021
Q2
$442K Buy
19,405
+2,360
+14% +$49.7K 0.04% 537
2021
Q1
$351K Buy
+17,045
New +$388K 0.02% 717
2020
Q3
Sell
-29,308
Closed -$604K 1684
2020
Q2
$604K Buy
+29,308
New +$399K 0.07% 311
2019
Q3
Sell
-12,544
Closed -$114K 1967
2019
Q2
$114K Buy
+12,544
New +$187K 0.01% 1119

Other funds holding MYOV

Virtu Financial's MYOV Position: Q2 2022 in Review

Virtu Financial sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 10,659 shares — an estimated $142K sold.

Virtu Financial first reported a position in MYOV in Q2 2019 and held it in 7 quarters. The position peaked at $604K in Q2 2020. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Virtu Financial reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 10,659 Myovant Sciences Ltd. shares in Q2 2022, an estimated $142K.
  • Virtu Financial first reported a position in Myovant Sciences Ltd. in Q2 2019 and held it in 7 quarters.
  • Virtu Financial's Myovant Sciences Ltd. position peaked at $604K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.